PDT in treatment of peri-implant diseases

Not Applicable

• Conditions: peri-implant diseases.; k05.6; K00-K14

• Registration Number: IRCT201309119260N2
• Lead Sponsor: this study was self-funded by researchers.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

•Presence of at least two screw type titanium dental implants, in different sites, exhibiting clinical and radiographic signs of peri-implant diseases (including peri-implant mucositis and peri-implantitis).
•No implant mobility
•No evidence of occlusal overload
•No treatment of peri-implant diseases for the least 6 months before the study
•No use of antibiotics and anti-inflammatory drugs for the 3 months prior treatment. If these drugs were taken during the study, patient would be excluded.
•At least 1 year function of implants.
•No pregnancy and nursing
•No uncontrolled diabetes (HbA1c < 7)
•In the cases that subjects had a history of periodontitis, only subjects were included if the lesions were treated at the remaining teeth and diseases was halted.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peri-implant probing pocket depth. Timepoint: before treatment, 1.5 and 3 months after treatment. Method of measurement: millimeter using williams plastic probe.;Peri-implant clinical attachment loss(CAL). Timepoint: before treatment, 1.5 and 3 months after treatment. Method of measurement: millimeter using williams plastic probe.

Secondary Outcome Measures

Name	Time	Method
Peri-implant bleeding after probing(BOP). Timepoint: before treatment, 1.5 and 3 months after treatment. Method of measurement: PBI index.;Peri-implant gingival index(GI). Timepoint: before treatment, 1.5 and 3 months after treatment. Method of measurement: gingival index.